Azalea Therapeutics
BiotechnologyWebsite
Operator of a biotechnology platform intended to enable precise genome editing inside the body for disease treatment. The company offers an Enveloped Delivery Vehicle technology that directs CRISPR-Ca...
Valuation
$153M
Market implied
Share Price
N/A
Total Raised
$82M
Last Round
Early Stage VC (Series A)
Oct 2025
Latest Funding Round
Early Stage VC (Series A)
Oct 30, 2025
$65M
raised
Investors
+6 other investors